{"id":"NCT00129402","sponsor":"Organon and Co","briefTitle":"Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)","officialTitle":"Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-08","primaryCompletion":"2007-06","completion":"2007-06","firstPosted":"2005-08-11","resultsPosted":"2010-02-11","lastUpdate":"2022-02-08"},"enrollment":248,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"ezetimibe with simvastatin","otherNames":[]},{"type":"DRUG","name":"simvastatin","otherNames":[]}],"arms":[{"label":"Pooled subjects who received ezetimibe with simvastatin","type":"EXPERIMENTAL"},{"label":"Pooled subjects who received simvastatin monotherapy","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomized, double-blind, controlled, parallel-group, multicenter, Phase-3 study to evaluate the efficacy and safety of ezetimibe with simvastatin taken alone in subjects ages 10-17 years with Heterozygous Familial Hypercholesterolemia.","primaryOutcome":{"measure":"Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C)","timeFrame":"baseline to 6 weeks","effectByArm":[{"arm":"Pooled Subjects Who Received Ezetimibe With Simvastatin","deltaMin":-49.45,"sd":1.19},{"arm":"Pooled Subjects Who Received Simvastatin Monotherapy","deltaMin":-34.43,"sd":1.22}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.01"}]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["18940534"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":126},"commonTop":["Nasopharyngitis","Headache","Influenza","Cough","Acne"]}}